NBRV logo

Nabriva Therapeutics (NBRV) Income Tax

Annual Income Tax

$1.57 M
+$1.08 M+220.00%

December 31, 2022

Summary

Performance

1-Year Change

+220%

3-Year Change

+1452.48%

5-Year Change

+15.72%

15-Year Change

+15.72%

NBRV Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.57 M
NBRV annual income tax is currently at an all-time high

3-Year Low

$490.00 K
NBRV annual income tax is currently +220.00% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
NBRV previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
NBRV next annual earnings announcement has not yet been scheduled

OtherNBRVexpensesmetrics:

Annual Total Expenses

$86.84 M
NBRV annual total expenses is $86.84 million

Annual Operating Expenses

$58.26 M
NBRV annual total operating expenses is $58.26 million

Annual Cost Of Goods Sold

$28.58 M
NBRV annual cost of goods sold is $28.58 million

Annual Interest Expense

$698.00 K
NBRV annual interest expense is $698.00 thousand

Quarterly Income Tax

$0.00
-$309.00 K-100.00%

March 31, 2023

Summary

Performance

3-Month Change

-100%

1-Year Change

-100%

3-Year Change

-100%

5-Year Change

-100%

NBRV Quarterly Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.87 M
NBRV quarterly income tax is currently -100.00% below its historical high of $1.87 million

3-Year Low

-$54.00 K

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
NBRV previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
NBRV next earnings announcement has not yet been scheduled

OtherNBRVexpensesmetrics:

Quarterly Total Expenses

$16.07 M
NBRV quarterly total expenses is $16.07 million

Quarterly Operating Expenses

$11.63 M
NBRV quarterly total operating expenses is $11.63 million

Quarterly Cost Of Goods Sold

$4.44 M
NBRV quarterly cost of goods sold is $4.44 million

Quarterly Interest Expense

$194.00 K
NBRV quarterly interest expense is $194.00 thousand

TTM Income Tax

$1.21 M
-$354.00 K-22.58%

March 31, 2023

Summary

Performance

3-Month Change

-22.58%

1-Year Change

+85.63%

3-Year Change

+1126.26%

5-Year Change

+1101.98%

NBRV TTM Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$2.43 M
NBRV TTM income tax is currently -50.06% below its historical high of $2.43 million

3-Year Low

$433.00 K
NBRV TTM income tax is currently +180.37% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
NBRV previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
NBRV next earnings announcement has not yet been scheduled

OtherNBRVexpensesmetrics:

Annual Total Expenses

$86.84 M
NBRV annual total expenses is $86.84 million

Annual Operating Expenses

$58.26 M
NBRV annual total operating expenses is $58.26 million

TTM Cost Of Goods Sold

$29.66 M
NBRV TTM cost of goods sold is $29.66 million

TTM Interest Expense

$677.00 K
NBRV TTM interest expense is $677.00 thousand

Income Tax Formula

Income Tax Expense = Current Tax Expense + Deferred Tax Expense

NBRV Income Tax Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+220.0%-100.0%+85.6%
3 y3 years+1452.5%-100.0%+1126.3%
5 y5 years+15.7%-100.0%+1102.0%

NBRV Income Tax Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-68.8%-100.0%<-9999.0%-22.6%-64.3%
5 y5-yearat high-93.6%-100.0%<-9999.0%-22.6%-91.8%
alltimeall timeat high-142.9%-100.0%<-9999.0%-50.1%-203.9%

Nabriva Therapeutics Income Tax History

DateAnnualQuarterlyTTM
Mar 2023
-
$0.00(-100.0%)
$1.21 M(-22.6%)
Dec 2022
$1.57 M(+220.0%)
$309.00 K(-40.6%)
$1.57 M(+30.1%)
Sep 2022
-
$520.00 K(+35.1%)
$1.21 M(+178.3%)
Jun 2022
-
$385.00 K(+8.8%)
$433.00 K(-33.8%)
Mar 2022
-
$354.00 K(-755.6%)
$654.00 K(+33.5%)
Dec 2021
$490.00 K(+252.5%)
-$54.00 K(-78.6%)
$490.00 K(+1.2%)
Sep 2021
-
-$252.00 K(-141.6%)
$484.00 K(-27.1%)
Jun 2021
-
$606.00 K(+218.9%)
$664.00 K(+275.1%)
Mar 2021
-
$190.00 K(-416.7%)
$177.00 K(+27.3%)
Dec 2020
$139.00 K(+37.6%)
-$60.00 K(-16.7%)
$139.00 K(-36.8%)
Sep 2020
-
-$72.00 K(-160.5%)
$220.00 K(-16.3%)
Jun 2020
-
$119.00 K(-21.7%)
$263.00 K(+165.7%)
Mar 2020
-
$152.00 K(+623.8%)
$99.00 K(-2.0%)
Dec 2019
$101.00 K(+106.1%)
$21.00 K(-172.4%)
$101.00 K(-156.7%)
Sep 2019
-
-$29.00 K(-35.6%)
-$178.00 K(-40.7%)
Jun 2019
-
-$45.00 K(-129.2%)
-$300.00 K(-1.0%)
Mar 2019
-
$154.00 K(-159.7%)
-$303.00 K(-718.4%)
Dec 2018
$49.00 K
-$258.00 K(+70.9%)
$49.00 K(-88.0%)
Sep 2018
-
-$151.00 K(+214.6%)
$408.00 K(-83.2%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$48.00 K(-109.5%)
$2.43 M(+60.8%)
Mar 2018
-
$506.00 K(+401.0%)
$1.51 M(+11.6%)
Dec 2017
$1.35 M(-301.6%)
$101.00 K(-94.6%)
$1.35 M(+132.4%)
Sep 2017
-
$1.87 M(-293.6%)
$583.00 K(-146.2%)
Jun 2017
-
-$967.00 K(-377.1%)
-$1.26 M(+312.1%)
Mar 2017
-
$349.00 K(-152.0%)
-$306.00 K(-54.5%)
Dec 2016
-$672.00 K(+51.0%)
-$671.00 K(-2496.4%)
-$672.00 K(+227.8%)
Sep 2016
-
$28.00 K(-333.3%)
-$205.00 K(-57.9%)
Jun 2016
-
-$12.00 K(-29.4%)
-$487.00 K(+3.0%)
Mar 2016
-
-$17.00 K(-91.7%)
-$473.00 K(+6.5%)
Dec 2015
-$445.00 K(-573.4%)
-$204.00 K(-19.7%)
-$444.00 K(+199.0%)
Sep 2015
-
-$254.00 K(<-9900.0%)
-$148.50 K(-241.0%)
Jun 2015
-
$2000.00(-83.3%)
$105.30 K(+0.6%)
Mar 2015
-
$12.00 K(-86.9%)
$104.70 K(+11.3%)
Dec 2014
$94.00 K(-91.2%)
$91.50 K(<-9900.0%)
$94.10 K(+3519.2%)
Sep 2014
-
-$200.00(-114.3%)
$2600.00(-7.1%)
Jun 2014
-
$1400.00(0.0%)
$2800.00(+100.0%)
Mar 2014
-
$1400.00
$1400.00
Dec 2013
$1.07 M
-
-

FAQ

  • What is Nabriva Therapeutics annual income tax?
  • What is the all time high annual income tax for Nabriva Therapeutics?
  • What is Nabriva Therapeutics annual income tax year-on-year change?
  • What is Nabriva Therapeutics quarterly income tax?
  • What is the all time high quarterly income tax for Nabriva Therapeutics?
  • What is Nabriva Therapeutics quarterly income tax year-on-year change?
  • What is Nabriva Therapeutics TTM income tax?
  • What is the all time high TTM income tax for Nabriva Therapeutics?
  • What is Nabriva Therapeutics TTM income tax year-on-year change?

What is Nabriva Therapeutics annual income tax?

The current annual income tax of NBRV is $1.57 M

What is the all time high annual income tax for Nabriva Therapeutics?

Nabriva Therapeutics all-time high annual income tax is $1.57 M

What is Nabriva Therapeutics annual income tax year-on-year change?

Over the past year, NBRV annual income tax has changed by +$1.08 M (+220.00%)

What is Nabriva Therapeutics quarterly income tax?

The current quarterly income tax of NBRV is $0.00

What is the all time high quarterly income tax for Nabriva Therapeutics?

Nabriva Therapeutics all-time high quarterly income tax is $1.87 M

What is Nabriva Therapeutics quarterly income tax year-on-year change?

Over the past year, NBRV quarterly income tax has changed by -$354.00 K (-100.00%)

What is Nabriva Therapeutics TTM income tax?

The current TTM income tax of NBRV is $1.21 M

What is the all time high TTM income tax for Nabriva Therapeutics?

Nabriva Therapeutics all-time high TTM income tax is $2.43 M

What is Nabriva Therapeutics TTM income tax year-on-year change?

Over the past year, NBRV TTM income tax has changed by +$560.00 K (+85.63%)